--- title: "Lifeon Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 90.2271 million yuan, an increase of 16.53%" type: "News" locale: "en" url: "https://longbridge.com/en/news/254416294.md" description: "According to the Zhitong Finance APP, Lifeon Pharmaceutical released its semi-annual report for 2025, with operating revenue of 732 million yuan, a year-on-year decrease of 4.80%. The net profit attributable to shareholders of the listed company was 90.2271 million yuan, a year-on-year increase of 16.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.2209 million yuan, a year-on-year decrease of 9.68%. The basic earnings per share were 0.47 yuan" datetime: "2025-08-25T10:37:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/254416294.md) - [en](https://longbridge.com/en/news/254416294.md) - [zh-HK](https://longbridge.com/zh-HK/news/254416294.md) generator: "portal-rs" --- # Lifeon Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 90.2271 million yuan, an increase of 16.53% According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) released its semi-annual report for 2025, showing an operating income of 732 million yuan, a year-on-year decrease of 4.80%. The net profit attributable to shareholders of the listed company was 90.2271 million yuan, a year-on-year increase of 16.53%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.2209 million yuan, a year-on-year decrease of 9.68%. The basic earnings per share were 0.47 yuan ### Related Stocks - [003020.CN](https://longbridge.com/en/quote/003020.CN.md) ## Related News & Research - [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md) - [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md) - [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md) - [Alpha Entrepreneurial Partners Investment TGV takes 3.03% stake in q.beyond voting rights](https://longbridge.com/en/news/296450706.md) - [Bucked UpĀ® Launches Hunt: Orange Cream, a Limited-Edition Flavor Built to Fuel Your Hunt](https://longbridge.com/en/news/296524338.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**